AB 1676 adds a new Section 5336.5 authorizing county behavioral health directors (or designees) to petition superior courts to order involuntary psychotropic medication for people placed under assisted outpatient treatment (AOT) or when filed separately. The petition triggers a clear-and-convincing evidentiary hearing and must include contemporaneous clinical affidavits, a physician or nurse practitioner’s finding that medication is necessary to prevent relapse or grave disability, and evidence that the person lacks capacity to refuse medication.
The measure ties any involuntary medication order to the duration of the AOT order (with a mechanism to seek a subsequent order up to 180 days), establishes procedural protections (consolidated hearings, a right to demand a court or jury trial on key issues, regular 60‑day judicial review via affidavits, and habeas corpus remedies), and permits limited transport to a designated facility for medication administration and evaluation. The provision changes how counties, clinicians, defenders, and first responders will coordinate in severe mental illness cases where refusal of medication is at issue.
At a Glance
What It Does
Authorizes the county behavioral health director to petition a superior court for an order authorizing involuntary psychotropic medication if the court finds, by clear and convincing evidence, specific clinical and capacity criteria are met. The order may run for the duration of an AOT order and may be extended for up to 180 days by subsequent court action.
Who It Affects
County behavioral health agencies and their clinicians (who must prepare affidavits and testify), superior courts and defense counsel handling mental-health matters, first responders asked to transport for medication administration, and people receiving or subject to assisted outpatient treatment and their advocates.
Why It Matters
This codifies a judicial path to compel medication in the outpatient/AOT context, imposing new operational duties on counties and clinicians while creating distinct due-process timelines and review checkpoints that defenders and courts will need to manage.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AB 1676 establishes a statutory petition procedure (Section 5336.5) allowing county behavioral health directors or designees to seek court orders for involuntary psychotropic medication. The petition must identify whether it is filed alongside a petition for aided outpatient treatment (Sections 5346 / 5346.5) and must state facts showing the person meets the bill’s criteria: a court-ordered AOT (or concurrent finding), a licensed provider’s diagnosis of a serious mental disorder, a physician or nurse practitioner’s determination that medications are required to prevent likely relapse or grave disability, and a finding that the person lacks capacity to refuse medication.
The petition must be accompanied by an affidavit from the clinicians who examined the person within ten days prior to filing and must describe attempts to obtain voluntary compliance.
Procedurally, the bill requires consolidation of hearings if the involuntary-medication petition and the AOT petition are filed together, with the court deciding the AOT petition before ruling on medication. The person subject to the petition receives expanded process rights: the right to a court or jury trial on whether they have a serious mental disorder, lack capacity, or need medication to prevent grave disability; a narrow timetable for demanding that trial (within five days after the hearing) and for commencement of the trial (generally within ten days of demand); counsel; and notice obligations.
If a person is absent from the original hearing, they may petition for habeas corpus before medication administration begins.On the enforcement side, a licensed AOT team member may request first responders to take an individual into custody and transport them to a designated facility for medication administration or evaluation only when the team concludes the person has refused or failed to comply, efforts to obtain cooperation were made, and the person needs evaluation for involuntary care or medication administration. If the transported person does not meet 5150 criteria within 72 hours and refuses voluntary admission, they must be released.
The statute limits the use of noncompliance with medication as the sole ground for civil commitment or contempt findings.The bill also sets a recurring review regime: every 60 days the county must file an affidavit affirming continued eligibility for involuntary medication and listing any medication changes; the person then has the right to a hearing challenging continued medication, with the county bearing the burden of proof. The county may seek a subsequent involuntary-medication order prior to expiration, for up to 180 days, following the same procedures.
The Five Things You Need to Know
Only the county behavioral health director or the director’s designee may file the petition for involuntary medication in the superior court where the person is present or believed to be present.
Clinical affidavits must state the exam occurred within 10 days of filing, document attempts to obtain voluntary cooperation, and show the clinicians are willing to testify at the hearing.
A person subject to the petition can demand a court or jury trial on diagnosis, capacity, and medical necessity within five days after the hearing; the trial must start within 10 days of the demand (with limited continuances).
An involuntary-medication order lasts for the duration of the AOT order and counties can apply for a subsequent order authorizing continued involuntary medication for up to 180 days.
Every 60 days the county must file an affidavit affirming the person still meets criteria and noting medication changes; the person has a right to a hearing to challenge the affidavit and the county bears the burden of proof.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Who may file and where
This subsection limits petitioning authority to the county behavioral health director or a designee and requires filing in the superior court where the person is present or reasonably believed to be present. Practically, counties—not individual clinicians or family members—control the decision to seek an involuntary-medication order, which centralizes responsibility and preserves a single institutional petitioner for coordination with counsel and the court.
Substantive criteria for an order
The court may authorize involuntary medication only on clear-and-convincing evidence that multiple conditions are met: an existing or concurrently granted AOT order, a licensed provider’s diagnosis of a serious mental disorder (as cross-referenced to Section 5600.3), a physician or nurse practitioner’s finding that medication is necessary to prevent likely relapse or grave disability, consideration of alternatives, and a determination that the person lacks capacity to refuse medication. This subsection ties legal authority to specific clinical determinations and requires clinicians to document consideration of alternatives before seeking forced medication.
Petition content and clinician affidavit requirements
The petition must list whether it is concurrent with an AOT petition, state facts supporting each statutory criterion, and alert the person to specified rights. It must be accompanied by an affidavit from the treating provider(s) who examined the person within 10 days, recount attempts to obtain voluntary compliance, explain why alternatives are unlikely to meet needs, and confirm willingness to testify. These filing requirements create a tight evidentiary record pre-hearing and put clinicians on notice they will be called to support the factual basis for coercive medication.
Hearing consolidation, timelines, and trial rights
If both petitions are filed together, the court must consolidate and decide the AOT petition before ruling on medication. The statute adopts expedited timing and preserves the person’s right to demand a court or jury trial on key issues within five days of the hearing, with the trial to commence within 10 days of demand (subject to limited continuance). Counsel and notice rules mirror those in Section 5346, so defense attorneys and patient‑rights offices will need to adapt to compressed schedules.
Order duration, transport, periodic review, extensions and remedies
An involuntary-medication order runs for the life of the AOT order and ends if the person is found to have regained capacity. The statute permits transport by first responders to a designated facility for medication administration and requires release if 5150 criteria are not met within 72 hours. Counties may seek an up-to-180-day continuation before expiration following the same procedures. Every 60 days the county must file an affidavit affirming continued criteria and noting medication changes, and the subject may challenge the affidavit or pursue habeas corpus; the county bears the burden at any such hearing. The statute forbids using mere noncompliance with medication as the sole basis for commitment or contempt.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- County behavioral health directors and AOT teams — gain a clear statutory mechanism to seek court-ordered medication when voluntary treatment fails, enabling them to pursue a clinical plan tied to court oversight.
- Clinicians treating patients under AOT — receive explicit statutory recognition that their medical determinations (diagnosis, capacity, medication necessity) can form the basis for court-ordered treatment, with a prescribed affidavit format.
- Family members and caregivers of people with severe mental illness — may see a legal route to address repeated refusal of medication that clinicians judge will lead to relapse or grave disability.
- Superior courts and judges — receive statutory guidance and evidentiary standards for adjudicating involuntary-medication disputes in the AOT context, reducing reliance on ad hoc practice.
Who Bears the Cost
- County behavioral health agencies — must resource case preparation, clinician exams within 10 days of filing, frequent 60‑day affidavits, court appearances, and potential transport and facility placements, increasing administrative and fiscal burdens.
- Clinicians who must examine and affidavit — face additional documentation and testimony obligations, potential forensic workload, and legal scrutiny of clinical judgments.
- First responders and designated facilities — could experience operational strain from transport requests and short-term holds for medication administration and evaluation under compressed timelines.
- Defense counsel and public defender offices — must respond rapidly to expedited hearing and trial timetables, prepare capacity and diagnostic defenses, and represent clients at more frequent review hearings, stretching limited legal resources.
- Patients who receive AOT — bear loss of decisional autonomy where courts find lack of capacity and may face involuntary medication in a facility; advocates will need to monitor use and safeguard due process.
Key Issues
The Core Tension
The central dilemma is reconciling the public interest in preventing relapse and grave disability through enforceable treatment plans with the individual’s constitutional and medical right to refuse psychotropic medication: the bill strengthens counties’ ability to compel medication under judicial oversight, but in doing so it risks expanding coercive treatment without clear, uniformly applied standards for capacity, alternatives, and resource-backed procedural safeguards.
The bill creates tightly coupled clinical and judicial processes but leaves several implementation frictions unresolved. It prescribes a 10‑day lookback for clinical exams and frequent 60‑day judicial attestations, which will increase clinician and county workload without an explicit funding stream.
The statute requires the physician or nurse practitioner to have considered alternatives, but it does not define what constitutes adequate efforts to pursue those alternatives, creating room for litigation over whether less coercive options were meaningfully tried. The transport provision limits where medication can be administered—generally to a designated facility—and the 72‑hour evaluation rule may produce rushed determinations or repeated cycles of transport and release if beds or facilities are scarce.
The bill also raises evidentiary and procedural tradeoffs: the clear-and-convincing standard is a high bar, but the compressed timelines for trial (demand within five days, trial within ten days) could disadvantage defense counsel and experts who need time to assemble contrary medical opinion. The statute forbids treating noncompliance alone as grounds for commitment, but the practical effect of pairing medication orders with AOT may still produce coercive leverage: continuation of community-based supports and mandated services can hinge on compliance with medication plans enforced by court order.
Finally, capacity assessments are left to clinicians or a court/hearing officer, but the bill does not articulate a standardized capacity test or required documentation beyond the affidavit, increasing the risk of inconsistent outcomes across counties.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.